U.S. Wound Care Market Revenue & Forecast Analysis, 2026-2035
The U.S. wound care market was evaluated at USD 9.3 billion in 2025 and is projected to grow at a CAGR of 4.4% from USD 9.6 billion in 2026 to USD 14.2 billion in 2035. The robust market expansion is primarily driven by the rising prevalence of chronic wounds, including diabetic foot ulcers, pressure ulcers, and venous leg ulcers, coupled with the growing geriatric population that is more susceptible to slow-healing wounds. Additionally, advancements in wound care technologies, increasing surgical procedures, and expanding home healthcare services are supporting the growth of the U.S. wound care market.
Market Overview
According to the 2023 study "Human Wound and Its Burden: Updated 2022 Compendium of Estimates", chronic wounds affect approximately 10.5 million U.S. Medicare beneficiaries, highlighting the substantial and growing burden of wound management in the United States.
The U.S. wound care market has expanded consistently over time, driven by the increasing prevalence of chronic wounds, rising diabetic and elderly populations, and growing awareness regarding effective wound management. Advancements in wound care products, including antimicrobial dressings, negative pressure wound therapy (NPWT), and bioactive wound healing solutions, have improved treatment outcomes and reduced healing times. For instance, in September 2024, Solventum launched the V.A.C. Peel and Place Dressing for negative pressure wound therapy, simplifying wound dressing application and supporting improved wound care efficiency across healthcare settings.
The U.S. wound care market is projected to experience significant growth throughout the forecast period due to the increasing incidence of chronic and surgical wounds, expanding home healthcare services, and continuous advancements in wound healing technologies. The growing adoption of advanced dressings, biologics, and NPWT systems is also contributing to market expansion. For instance, by 2035, U.S. hospitals, wound care centers, and home healthcare providers are expected to significantly increase their use of next-generation wound care products developed by companies such as Smith+Nephew, driven by the need to improve healing outcomes, reduce complications, and lower healthcare costs associated with chronic wounds.
U.S. Wound Care Market Overview
Base Year Market Size (2025): USD 9.3 Billion
CAGR: 4.4%
Forecast Year Market Size (2035): USD 14.2 Billion
Major Players:
Smith+Nephew
Solventum
Mölnlycke Health Care
ConvaTec Group
Cardinal Health
U.S. Wound Care Market Trends
The U.S. wound care market is evolving rapidly due to the increasing burden of chronic wounds, technological advancements in wound management, and the growing emphasis on cost-effective treatment solutions.
The rising adoption of advanced wound dressings, including foam, hydrocolloid, alginate, and hydrofiber dressings, is improving wound healing efficiency and patient comfort.
The growing integration of digital wound assessment and monitoring tools is enabling healthcare providers to track wound progression more accurately and optimize treatment plans.
The increasing use of biologics and regenerative wound care products, such as skin substitutes and growth factor-based therapies, is enhancing healing outcomes for complex and chronic wounds.
The expansion of home-based wound care services is driving demand for portable and easy-to-use wound management products, helping reduce hospital visits and treatment costs.
Furthermore, healthcare providers are increasingly focusing on value-based care models, encouraging the adoption of wound care solutions that improve healing rates while reducing complications and readmissions.
Collectively, these trends are expected to support the continued growth of the U.S. wound care market by improving treatment effectiveness, patient convenience, and overall healthcare efficiency.
U.S. Wound Care Market Analysis
By Product Type
Advanced wound care products dominate the U.S. wound care market due to their effectiveness in treating complex wounds
Based on the product type, the U.S. wound care market is categorized into advanced wound care products, traditional wound care products, and wound therapy devices. The advanced wound care products segment leads the market with the highest market share in 2025.
By Wound Type
Chronic wounds dominate the U.S. wound care market owing to their high prevalence and long treatment duration
Based on the wound type, the U.S. wound care market is categorized into chronic wounds and acute wounds. The chronic wounds segment leads the market with the highest market share in 2025.
By End-use
Hospitals dominate the U.S. wound care market due to high patient volumes and advanced wound management capabilities.
Based on the end-use, the U.S. wound care market is categorized into hospitals, specialty centers, and others. The hospitals segment leads the market with the highest market share in 2025.
Key Companies Profiled
The U.S. wound care market features a competitive landscape with leading wound care and medical technology companies competing through advanced dressings, wound therapy devices, and regenerative wound care solutions. Key players such as Smith+Nephew, Solventum (formerly 3M Health Care), Mölnlycke Health Care, ConvaTec Group, and Cardinal Health hold a significant share of the market, supported by broad product portfolios, strong distribution networks, and continuous product innovation.
The market is highly competitive, with companies focusing on advanced wound dressings, negative pressure wound therapy (NPWT) systems, antimicrobial products, and biologic wound care solutions to strengthen their market positions. The growing prevalence of chronic wounds, increasing surgical procedures, and rising demand for cost-effective wound management are further intensifying competition across healthcare settings. For instance, in 2024, Smith+Nephew introduced the RENASYS EDGE NPWT System in the U.S., reinforcing competition in the advanced wound care segment.
U.S. Wound Care Market Companies:
Some of the key companies operating in the U.S. Wound Care Market include:
B. Braun SE
Baxter International
Cardinal Health
Coloplast
ConvaTec Group
Integra LifeSciences
Johnson & Johnson MedTech (Ethicon)
Medline Industries, Inc.
Medtronic plc
MiMedx Group, Inc.
Mölnlycke Health Care
Organogenesis Holdings Inc.
Smith+Nephew
Solventum (fomerly 3M Health Care)
URGO Medical North America
Market Segmentation
This study provides revenue growth and emerging trends across the U.S. levels from 2021 to 2035, segmenting the U.S. wound care market by-
Product Type (Revenue in USD Million, 2021 - 2035)
Advanced Wound Care Products
Advanced Wound Dressings
Foam dressings
Hydrocolloid dressings
Hydrogel dressings
Alginate dressings
Film dressings
Collagen dressings
Antimicrobial Dressings
Silver-based dressings
Iodine-based dressings
Honey-impregnated dressings
Traditional Wound Care Products
Gauze dressings
Bandages
Cotton wool
Adhesive tapes
Wound Therapy Devices
Negative Pressure Wound Therapy (NPWT) Devices
Oxygen Therapy Devices
Others
Wound Type (Revenue in USD Million, 2021 - 2035)
Chronic Wounds
Diabetic foot ulcers
Pressure ulcers
Venous leg ulcers
Acute Wounds
Surgical wounds
Traumatic wounds
Burns
End-use (Revenue in USD Million, 2021 – 2035)
Hospitals
Specailty Centers
Others
Table of Content
1. Methodology and Scope
1.1. Scope of the Study
1.1.1. Market Segmentation
1.1.2. Market Definition
1.1.3. Inclusions and Exclusions of the Study
1.2. Research Design
1.2.1. Base Year, Historical Data, and Forecast Period
1.2.2. Data Collection Methods
1.2.2.1. Secondary Sources
1.2.2.2. Primary Sources
1.2.3. Research Methodology
1.2.3.1. Base Year Calculation/ Parent Market Analysis, Company/ Brand Share Analysis, 2025 (Top-down Approach)
1.2.3.2. Volume-Price Approach (Bottom-up Approach)
1.2.3.3. Data Triangulation
1.2.4. Forecasting Model
1.3. Research Assumptions
1.4. Validation and Data Quality Control
1.5. List of Primary Sources
1.6. List of Secondary Sources
2. Executive Summary
2.1. Market Overview
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
3. Industry Outlook
3.1. Industry Ecosystem Analysis
3.2. Parent/ Ancillary Market Analysis
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Restraints/ Challenges
3.3.3. Opportunities
3.4. Value Chain Analysis
3.5. Technology Roadmap
3.6. Porters Analysis
3.7. PESTLE Analysis
4. Market Estimates and Forecasts, By Product Type, 2021 - 2035 (Market Size in USD Mn)
4.1. Advanced Wound Care Products
4.1.1. Advanced Wound Dressings
4.1.1.1. Foam dressings
4.1.1.2. Hydrocolloid dressings
4.1.1.3. Hydrogel dressings
4.1.1.4. Alginate dressings
4.1.1.5. Film dressings
4.1.1.6. Collagen dressings
4.1.2. Antimicrobial Dressings
4.1.2.1. Silver-based dressings
4.1.2.2. Iodine-based dressings
4.1.2.3. Honey-impregnated dressings
4.2. Traditional Wound Care Products
4.2.1. Gauze dressings
4.2.2. Bandages
4.2.3. Cotton wool
4.2.4. Adhesive tapes
4.3. Wound Therapy Devices
4.3.1. Negative Pressure Wound Therapy (NPWT) Devices
4.3.2. Oxygen Therapy Devices
4.4. Others
5. Market Estimates and Forecasts, By Wound Type, 2021 – 2035 (USD Mn)
5.1. Chronic Wounds
5.1.1. Diabetic foot ulcers
5.1.2. Pressure ulcers
5.1.3. Venous leg ulcers
5.2. Acute Wounds
5.2.1. Surgical wounds
5.2.2. Traumatic wounds
5.3. Burns
6. Market Estimates and Forecasts, By End-use, 2021 – 2035 (USD Mn)
6.1. Hospitals
6.2. Specailty Centers
6.3. Others
7. Market Estimates and Forecasts, By U.S., 2021 - 2035 (USD Mn)
7.1.1. U.S.
7.1.1.1. U.S. Wound Care Market Estimates and Forecasts to 2035 (USD Mn)
7.1.1.2. Market Dynamics
7.1.1.3. Competitive Landscape
7.1.1.4. Regulatory Framework
7.1.1.5. Reimbursement Scenario
8. Competitive Landscape
8.1. Company Market Share Analysis, 2025
8.2. Company Tier Structure
8.3. List of Major Suppliers, By Key Countries
8.4. Key Company Positioning Analysis
8.5. Company Profile
8.5.1. Smith+Nephew
8.5.2. Solventum (formerly 3M Health Care)
8.5.3. Mölnlycke Health Care
8.5.4. ConvaTec Group
8.5.5. Cardinal Health
8.5.6. Coloplast
8.5.7. Baxter International
8.5.8. Medtronic plc
8.5.9. Integra LifeSciences
8.5.10. Organogenesis Holdings Inc.
8.5.11. MiMedx Group, Inc.
8.5.12. Medline Industries, Inc.
8.5.13. Johnson & Johnson MedTech (Ethicon)
8.5.14. B. Braun SE
8.5.15. URGO Medical North America
9. Analyst Perspective
10. Related Reports
Related Research
Revolution Insights Briefs
Stay informed with updates on related market reports and key industry topics.